Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)
2.070
+0.120
(+6.15%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2025
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Monday's pre-market session: top gainers and losers ↗
December 15, 2025
Let's take a look at the stocks that are in motion in today's session. ↗
December 12, 2025
Which stocks are moving on Friday? ↗
July 11, 2025
Top movers in Friday's session ↗
March 28, 2025
12 Health Care Stocks Moving In Friday's Intraday Session ↗
March 28, 2025
Top movers in Friday's pre-market session ↗
March 28, 2025
Why Is Milestone Pharmaceuticals Stock Plunging Today? ↗
March 28, 2025
Frequently Asked QuestionsIs Milestone Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Milestone Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Milestone Pharmaceuticals Inc. - Common Shares trade on?
Milestone Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Milestone Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Milestone Pharmaceuticals Inc. - Common Shares is MIST on the Nasdaq Stock Market
What is the current price of Milestone Pharmaceuticals Inc. - Common Shares?
The current price of Milestone Pharmaceuticals Inc. - Common Shares is 2.070
When was Milestone Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Milestone Pharmaceuticals Inc. - Common Shares was at 12/24/25 01:00 PM ET
What is the market capitalization of Milestone Pharmaceuticals Inc. - Common Shares?
The market capitalization of Milestone Pharmaceuticals Inc. - Common Shares is 110.44M
How many shares of Milestone Pharmaceuticals Inc. - Common Shares are outstanding?
Milestone Pharmaceuticals Inc. - Common Shares has 110M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
